In GOSR2-associated disorders, previous attempts at genotype–phenotype analyses suggested a correlation between residual protein expression and disease severity, ultimately proposing a disease spectrum between PME with missense variants at the milder end and congenital muscular dystrophy with splice site variants at the more severe end [22]. The gene discussed is GOSR2; the disease is congenital muscular dystrophy.